Critical Reduction in β-Cell Mass Results in Two Distinct Outcomes over Time
Open Access
- 1 January 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (5), 2997-3005
- https://doi.org/10.1074/jbc.m210581200
Abstract
We have proposed that hyperglycemia-induced dedifferentiation of β-cells is a critical factor for the loss of insulin secretory function in diabetes. Here we examined the effects of the duration of hyperglycemia on gene expression in islets of partially pancreatectomized (Px) rats. Islets were isolated, and mRNA was extracted from rats 4 and 14 weeks after Px or sham Px surgery. Px rats developed different degrees of hyperglycemia; low hyperglycemia was assigned to Px rats with fed blood glucose levels less than 150 mg/dl, and high hyperglycemia was assigned above 150 mg/dl. β-Cell hypertrophy was present at both 4 and 14 weeks. At the same time points, high hyperglycemia rats showed a global alteration in gene expression with decreased mRNA for insulin, IAPP, islet-associated transcription factors (pancreatic and duodenal homeobox-1, BETA2/NeuroD, Nkx6.1, and hepatocyte nuclear factor 1α), β-cell metabolic enzymes (glucose transporter 2, glucokinase, mitochondrial glycerol phosphate dehydrogenase, and pyruvate carboxylase), and ion channels/pumps (Kir6.2, VDCCβ, and sarcoplasmic reticulum Ca2+-ATPase 3). Conversely, genes normally suppressed in β-cells, such as lactate dehydrogenase-A, hexokinase I, glucose-6-phosphatase, stress genes (heme oxygenase-1, A20, and Fas), and the transcription factor c-Myc, were markedly increased. In contrast, gene expression in low hyperglycemia rats was only minimally changed at 4 weeks but significantly changed at 14 weeks, indicating that even low levels of hyperglycemia induce β-cell dedifferentiation over time. In addition, whereas 2 weeks of correction of hyperglycemia completely reverses the changes in gene expression of Px rats at 4 weeks, the changes at 14 weeks were only partially reversed, indicating that the phenotype becomes resistant to reversal in the long term. In conclusion, chronic hyperglycemia induces a progressive loss of β-cell phenotype with decreased expression of β-cell-associated genes and increased expression of normally suppressed genes, these changes being present with even minimal levels of hyperglycemia. Thus, both the severity and duration of hyperglycemia appear to contribute to the deterioration of the β-cell phenotype found in diabetes.Keywords
This publication has 43 references indexed in Scilit:
- Beta-cell adaptation and decompensation during the progression of diabetes.Diabetes, 2001
- Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of β-cell formation in the pancreasDevelopment, 2000
- Metabolic control ofβ-cell functionSeminars in Cell & Developmental Biology, 2000
- Transcription factors involved in pancreatic islet developmentJournal of Biomedical Science, 2000
- Chronic Hyperglycemia Triggers Loss of Pancreatic β Cell Differentiation in an Animal Model of DiabetesJournal of Biological Chemistry, 1999
- β-Cell-specific inactivation of the mouseIpf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetesGenes & Development, 1998
- Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.Diabetes, 1998
- Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/NeuroD-deficient miceGenes & Development, 1997
- The β cell transcription factors and development of the pancreasJournal of Molecular Medicine, 1997
- Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null AllelesCell, 1997